Gender-Neutral Vaccination Prevents Oncogenic HPV Most Effectively
Karolinska Institutet
Vaccinating boys and girls induces herd immunity that helps eradicate oncogenic HPV types more quickly
HPV
E. coli-Produced HPV Vaccine Proves to Be Safe in Phase 2 Trial
Science China Press
The recombinant 9-valent HPV vaccine was well tolerated by all participants and caused no serious adverse effects
Novel Test Helps Detect Often-Missed Cervical Adenocarcinoma
Albert Einstein College of Medicine
Women with a high DNA methylation score would be prone to HPV infection, AIS, and ADC
One in Three Men Worldwide Infected with Genital HPV
World Health Organization
Human papillomavirus infections are associated with cancers and significant morbidity, and lead to increased transmission rates
Innovations for Equitable Cervical Cancer Screening
Swathi Kodaikal, MSc
Accessible screening tests and inclusive management strategies could reduce cervical cancer globally
WHO Prequalifies Additional HPV Test, Accelerates Efforts Toward Cervical Cancer Elimination
World Health Organization
HPV tests perform better than alternative screening methods and help identify more patients in need of treatment
How Can Clinical Labs Support Comprehensive Cervical Cancer Screening?
Hologic
Pap and HPV testing together is highly sensitive and offers the most comprehensive defense against rising rates of cervical cancer
AACC Updates Guidance to Improve Cervical Cancer Detection
American Association for Clinical Chemistry
Updated guidance addresses key questions related to cervical cancer management and introduces lab report templates for clinicians
FDA Approves Use of BD’s HPV Assay with Pap Tests
Becton, Dickinson and Company
Approval expands access to the HPV test that more precisely identifies risk for cervical cancer in patients
Parsing the Genetic Drivers of Head and Neck Cancers
University of California - San Diego
The most lethal form of head and neck cancer is linked to chromosomal alterations